The Federal Trade Commission (FTC) may be nearing settlements with the remaining two pharmacy benefit managers involved in a lawsuit over insulin pricing. | The Federal Trade Commission may be nearing ...
It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, ...
New Haven is pressing claims under the Racketeer Influenced and Corrupt Organizations Act, the Sherman Antitrust Act, the Connecticut Antitrust Act, and the Connecticut Unfair Trade Practices Act, and ...
Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.
Connecticut cities accuse PBMs and drugmakers of an insulin pricing scheme, filing federal lawsuits seeking damages and injunctions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results